A synaptic nidogen: developmental regulation and role of nidogen-2 at the neuromuscular junction by Fox, Michael A. et al.
BioMed Central
Page 1 of 17
(page number not for citation purposes)
Neural Development
Open AccessResearch article
A synaptic nidogen: Developmental regulation and role of 
nidogen-2 at the neuromuscular junction
Michael A Fox1,2, Matthew SP Ho3, Neil Smyth4 and Joshua R Sanes*1
Address: 1Department of Molecular and Cellular Biology and Center for Brain Science, Harvard University, Cambridge, MA 02138, USA, 
2Department of Anatomy and Neurobiology, Virginia Commonwealth University Medical Campus, Richmond, VA 23298-0709, USA, 3Center for 
Biochemistry and Center for Molecular Medicine, Medical Faculty, University of Cologne, D-50924, Cologne, Germany and 4School of Biological 
Sciences, University of Southampton, Southampton, SO16 7PX, UK
Email: Michael A Fox - mafox@vcu.edu; Matthew SP Ho - sai.ho@uni-koeln.de; Neil Smyth - N.R.Smyth@soton.ac.uk; 
Joshua R Sanes* - sanesj@mcb.harvard.edu
* Corresponding author    
Abstract
Background: The skeletal neuromuscular junction is a useful model for elucidating mechanisms
that regulate synaptogenesis. Developmentally important intercellular interactions at the
neuromuscular junction are mediated by the synaptic portion of a basal lamina that completely
ensheaths each muscle fiber. Basal laminas in general are composed of four main types of
glycosylated proteins: laminins, collagens IV, heparan sulfate proteoglycans and nidogens
(entactins). The portion of the muscle fiber basal lamina that passes between the motor nerve
terminal and postsynaptic membrane has been shown to bear distinct isoforms of the first three of
these. For laminins and collagens IV, the proteins are deposited by the muscle; a synaptic
proteoglycan, z-agrin, is deposited by the nerve. In each case, the synaptic isoform plays key roles
in organizing the neuromuscular junction. Here, we analyze the fourth family, composed of
nidogen-1 and -2.
Results: In adult muscle, nidogen-1 is present throughout muscle fiber basal lamina, while nidogen-
2 is concentrated at synapses. Nidogen-2 is initially present throughout muscle basal lamina, but is
lost from extrasynaptic regions during the first three postnatal weeks. Neuromuscular junctions in
mutant mice lacking nidogen-2 appear normal at birth, but become topologically abnormal as they
mature. Synaptic laminins, collagens IV and heparan sulfate proteoglycans persist in the absence of
nidogen-2, suggesting the phenotype is not secondary to a general defect in the integrity of synaptic
basal lamina. Further genetic studies suggest that synaptic localization of each of the four families
of synaptic basal lamina components is independent of the other three.
Conclusion: All four core components of the basal lamina have synaptically enriched isoforms.
Together, they form a highly specialized synaptic cleft material. Individually, they play distinct roles
in the formation, maturation and maintenance of the neuromuscular junction.
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Background
The formation, maturation and maintenance of chemical
synapses require multiple interactions between pre- and
postsynaptic elements. Many of these interactions are
mediated by membrane- or matrix-associated proteins
that occupy the narrow cleft separating the pre- and post-
synaptic membranes [1-3]. At the skeletal neuromuscular
junction (NMJ), where such interactions have been ana-
lyzed in detail, a basal lamina (BL) passing between the
motor nerve terminal and the postsynaptic membrane
comprises the cleft material of this synapse. As expected
from this arrangement, several of the molecules required
for the formation, maturation and maintenance of the
NMJ are BL components [4,5].
Members of four families of proteins are present in BLs
throughout the body: laminins, collagens IV, heparan sul-
fate proteoglycans (HSPGs), and nidogens/entactins
(referred to here as nidogens) [6]. Synaptic and extrasyn-
aptic portions of the muscle fiber BL are known to bear
distinct isoforms of the first three of these [4,5]. Laminins
are large heterotrimers composed of ?,?, and ? subunits.
The major laminin in extrasynaptic BL is the ?2?1?1 het-
erotrimer, called laminin 211. In contrast, synaptic BL is
rich in ?2 but poor in ?1 laminins, and contains, along
with ?2, the ?4 and ?5 subunits, both present at low lev-
els extrasynaptically. Thus, synaptic BL contains laminins
221, 421, and 521 [7-10]. Collagens IV are trimers assem-
bled from a set of six ? chains. All muscle BL contains the
?1 and ?2 chains, likely in an [?1(IV)]2[?2(IV)]1 trimer,
whereas the ?3–6 chains are selectively associated with
synaptic BL, presumably in [?3(IV)][?4(IV)][?5(IV)] and
[?5(IV)]2[?6(IV)]1 trimers [8,11,12]. The HSPG perlecan
is present in both synaptic and extrasynaptic BL, whereas
another HSPG, agrin, is concentrated in the synaptic BL
[13-15]. Importantly, studies of targeted mutant mice
have shown that synaptic isoforms of all three families act
as muscle-derived (laminins and collagens IV) or nerve-
derived (agrin) synaptic organizers in vivo. Laminin ?2
promotes the maturation of motor nerve terminals
[16,17], laminin ?4 regulates the precise apposition of
pre- and postsynaptic specializations [18], and together
laminins ?4 and ?5 promote the maturation of postsyn-
aptic specializations [19]. Synaptic collagen chains are
required for nerve terminal maintenance [12], and agrin is
a critical stabilizer of postsynaptic differentiation [20-25].
In contrast to this wealth of knowledge about laminins,
collagens IV and HSPGs, little is known about localization
or roles of nidogens at the neuromuscular synapse. In
Caenorhabditis elegans, the lone nidogen gene is necessary
for the formation of the NMJ, although the protein is not
synaptically enriched [26]. Unlike invertebrate genomes,
two nidogen genes are present in mammals, encoding
nidogen-1 and nidogen-2 [27-30]. In many tissues, mam-
malian nidogens are colocalized in BLs [31-33], and
genetic studies suggest that they play largely redundant
roles. Few phenotypes have been observed in targeted
mutants lacking either nidogen-1 or nidogen-2, whereas
double mutants lacking both nidogens die perinatally
with defects in lung, heart and limb development [32-36].
Moreover, expression of nidogen-2 is dramatically
increased in nidogen-1 mutants [32], supporting the
notion that nidogens are capable of compensating for
each other. In contrast, we show here that nidogen-2 is
selectively associated with synaptic BL in muscle and is
required for the maturation and maintenance of the adult
NMJ. Synaptic laminins, collagens IV and heparan sulfate
proteoglycans persist in the absence of nidogen-2, sug-
gesting that its role extends beyond maintaining the integ-
rity of the BL. Finally, we provide genetic evidence that
synaptic localization of each of the four families of BL
components is independent of the other three. Taken
together with the work cited above, these results show that
all four families of BL components have synapse-specific
isoforms and synapse-specific functions.
Results and discussion
Selective association of nidogen-2 with neuromuscular 
synapses
Nidogens-1 and -2 are similar in domain structure but dif-
fer in sequence (46% amino acid similarity in human,
43% in mouse [29,30,37]). To examine their distribution
we sought isoform-specific antibodies. Equal quantities of
full-length recombinant nidogen-1 and -2 were separated
electrophoretically and immunoblotted with several com-
mercially available antibodies. Antibodies were identified
that reacted strongly and selectively with each nidogen
isoform (Figure 1A, B). These antibodies were then used
to localize nidogens in muscle.
As shown previously [32], nidogen-1 was associated with
surfaces of adult muscle fibers whereas little if any
nidogen-2 was detectable on most of the muscle fiber sur-
face (Figure 1C, D). Nidogen-2 was, however, present on
many small structures associated with muscle fibers. Most
of these were capillaries that lie between muscle fibers (see
below) but a minority resembled synaptic sites in size,
shape and position. We therefore double-labelled muscle
sections with nidogen antibodies plus a fluorescent deriv-
ative of ?-bungarotoxin, which binds specifically to the
acetylcholine receptors (AChRs) concentrated in the post-
synaptic membrane at the NMJ. This demonstrated that
synaptic sites did indeed contain nidogen-2 (Figure 1E).
To localize nidogen-2 within the NMJ, we examined cross-
and en face-sectioned NMJs, allowing us to distinguish
three distinct domains in BL near synaptic sites: synaptic
BL, which occupies the synaptic cleft; extrasynaptic BL, in
directly adjoining stretches of the muscle fiber surface;
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and Schwann cell BL, atop Schwann cell processes that
themselves cap nerve terminals (Figure 2A). Nidogen-1
was present in all three of these domains, whereas
nidogen-2 was present in both synaptic and Schwann cell
BLs but absent from extrasynaptic BL (Figures 2B–D).
On the basis of these findings, we investigated the rela-
tionship between nidogen-2 and the antigen recognized
by the monoclonal antibody, 9H6, described by Chiu and
Ko [38]. 9H6 selectively stains NMJs in rat and binds a car-
bohydrate-dependent epitope on a nidogen-1-like anti-
gen. This antibody was described prior to the discovery of
nidogen-2, so it seemed possible that it recognized
nidogen-2. Because 9H6 fails to cross-react with mouse
tissue, we stained rat muscle with anti-nidogen-2. In rats,
as in mice, nidogen-2 was present at NMJs and in capillar-
ies (data not shown), whereas 9H6 stained only NMJs
[38]. Other differences in staining pattern are discussed
below. Moreover, on immunoblots, 9H6 recognizes a
protein with a molecular weight of 150 kDa [38], which is
the expected size of mammalian nidogen-1 and consider-
ably smaller than nidogen-2 (Figure 1A, B). These differ-
ences argue that the 9H6-antigen is not nidogen-2. Thus,
synaptic BL may contain both a synapse-specific isoform
of nidogen (nidogen-2) and a unique, glycosylated form
of nidogen-1.
Synaptic BL can be deposited by muscles fibers, motor
nerve terminals or Schwann cells [4,5,39]. Both muscle
and Schwann cells have been reported to express nidogen-
2 [40,41]. To determine whether muscle cells can contrib-
ute nidogen-2 to the synaptic cleft, we used a muscle cell
line, C2C12. These cells were fused into myotubes on
laminin substrata to promote AChR clustering [42].
Nidogen-2 was enriched at these AChR-rich sites even
though no non-muscle cells were present in the cultures
(Figure 2E). Thus, muscle cells are capable of nidogen-2
synthesis, secretion, and accumulation at synaptic sites.
As noted in the introduction, synaptic isoforms have been
demonstrated for three of the families of core BL compo-
nents – laminins, collagens IV and HSPGs [4,5]. Our
results add the fourth, nidogen, to this list. The presence
of synapse-specific isoforms of common BL components
provides a molecular explanation for the observations
that synaptic and extrasynaptic BLs are structurally similar
and physically continuous but functionally distinct.
Differential distribution of nidogens-1 and -2 in peripheral 
nerve
Next, we assessed the distribution of nidogen-1 and -2 in
the BLs of peripheral nerves. The BL of the perineurium,
which surrounds entire axon fascicles, was rich in both
nidogens-1 and -2, whereas the BL of the endoneurium,
which surrounds individual non-myelinating or myeli-
nating Schwann cells, was rich in nidogen-1 but poor in
nidogen-2 (Figure 3A, B). In contrast, antibody 9H6 labels
endoneurial but not perineurial BL in rat [38], consistent
Nidogen isoforms are differentially expressed in mouse mus-cle.Figur  1
Nidogen isoforms are differentially expressed in 
mouse muscle. (A, B) Western blotting of recombinant 
nidogen-1 (N1) and -2 (N2) demonstrates specificity of 
nidogen-1 and nidogen-2 antibodies. (C, D) Young adult 
(postnatal day 56) mouse muscle cross-sectioned and immu-
nostained with anti-nidogen-1 (C) or anti-nidogen-2 (D) anti-
bodies. Nidogen-1 is present in the basal lamina surrounding 
muscle fibers. Nidogen-2 is largely absent from muscle fiber 
basal lamina, but is present in discrete basal laminas within 
muscle. (E, E') Double labeling of muscle with ?-bungaro-
toxin (E) and anti-nidogen-2 (E') reveals that nidogen-2 is 
present at acetylcholine receptor-rich synaptic sites 
(arrows). Scale bar is 25 ?m.
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with the idea that it recognizes a subset of nidogen-1 mol-
ecules but not nidogen-2.
A few structures within the nerve fascicle were rich in
nidogen-2 (arrowheads in Figure 3B). Although some of
these may be capillaries, most were not associated with
CD31/PECAM-1, an endothelial cell marker ([43] and
data not shown). Instead, they are likely to be the BL sur-
rounding non-myelinating Schwann cells and their asso-
ciated bundle of small-caliber, non-myelinated axons
[41]. This localization is consistent with the observation
that nidogen-2 is present in the BL of terminal Schwann
cells (Figure 2C), which are non-myelinating.
Nidogen-1 and -2 were also differentially distributed in
BLs of muscle spindles, sensory organs that respond to
muscle stretch. Each spindle contains several specialized
intrafusal muscle fibers, all of which are surrounded by a
capsule BL. Intrafusal fiber BL was rich in nidogen-1, but
poor in nidogen-2, whereas spindle capsule BL was rich in
nidogen-2 but poor in nidogen-1 (Figure 3C, D). In con-
trast, BLs of intramuscular capillaries, venules, and arteri-
oles all contained both nidogen proteins (Figure 3E–H
and data not shown). To our knowledge, the spindle cap-
sule is the only BL found to date that bears nidogen-2 but
not nidogen-1.
Differential distribution of nidogens at the neuromuscular junction (NMJ)Figu  2
Differential distribution of nidogens at the neuromuscular junction (NMJ). (A) Schematic representation of the 
three cellular components of the NMJ (motor nerve terminal (NT), peri-synaptic Schwann cell process (SC), and skeletal mus-
cle fibers (M)) and the basal laminas (BLs) that coat them (dashed lines). Dashed lines: red, synaptic BL; blue, extrasynaptic BL; 
green, Schwann cell BL. (B-C") Young adult NMJ cross-sections costained with ?-bungarotoxin (BTX) and either anti-nidogen-
1 (B) or anti-nidogen-2 (C). Nidogen-1 is present in synaptic, extrasynaptic (arrows in B', B") and Schwann cell BLs (arrow-
heads in B', B"). Nidogen-2 is absent extrasynaptically, but is enriched in synaptic and Schwann cell BLs (arrowheads in C', C"). 
(D-D") Confocal, en face image of an NMJ double-stained with BTX and anti-nidogen-2. Regions of co-localization demonstrate 
nidogen-2-rich synaptic BL. Tube-like structures overlaying synaptic sites (arrowheads) represent Schwann cell BL. Nidogen-2-
positive structures near synaptic sites are capillaries (asterisks). (E-E") Nidogen-2 localized to acetylcholine receptor-rich 
(BTX-stained) sites in C2C12 myotubes. Scale bars are 5 ?m in (B, C) and 20 ?m in (D, E).
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Developmental regulation of nidogens at the synaptic BL
The distribution of some laminins, collagens IV, and
HSPGs in muscle fiber BL changes as development pro-
ceeds [9,11,12,44]. We asked whether the same was true
of nidogens. At birth, both nidogen-1 and nidogen-2 were
present throughout both synaptic and extrasynaptic mus-
cle fiber BL (Figure 4A, D). Similar patterns were present
through the first postnatal week (data not shown). More-
over, levels of nidogen-1 in synaptic and extrasynaptic BL
remained similar into adulthood (Figures 4B, C). In con-
trast, levels of nidogen-2 decreased in extrasynaptic BL
during the second postnatal week, so synaptic and
Schwann cell BL contained more nidogen-2 than extrasy-
naptic BL by postnatal day (P) 14 (Figure 4E). By P21,
nidogen-2 was undetectable in extrasynaptic BL (Figure
4F). Thus, nidogen-2 becomes restricted to synaptic sites
as the NMJ matures. Because our methods are not quanti-
tative, we do not know whether the decreased abundance
of nidogen-2 in extrasynaptic BL is accompanied by an
increased abundance in synaptic and Schwann cell BLs.
We asked whether the time course with which nidogen-2
became restricted to the NMJ was similar to that of lam-
inins ?4 and ?5, which are present extrasynaptically at
birth but restricted to synaptic BL in adults [9]. In fact, the
?4 and ?5 laminin chains, like nidogen-2, were present
throughout muscle fiber BL in neonates, were present at
markedly higher levels synaptically than extrasynaptically
by P14, and were largely synapse-specific by P21 (Figure
4G–L). Agrin is lost from extrasynaptic BL with a similar
time course [44]. Thus, there may be a coordinated altera-
tion in the composition of muscle fiber BL as develop-
ment proceeds, similar to, but later than, the initial broad
distribution and eventual synaptic concentration of
AChRs [39]. In contrast, laminin ?2 and synaptic collagen
IV chains are synaptically concentrated from their initial
appearance during embryogenesis and during the third
postnatal week, respectively [9,12]. Thus, whereas the
maturation of extrasynaptic BL may occur in a concerted
fashion, the distinctions between synaptic and extrasyn-
aptic BLs arise in a series of multiple steps.
Figure 3
Differential localization of nidogen isoforms in peripheral nerveFigu  3
Differential localization of nidogen isoforms in 
peripheral nerve. (A, B) Nidogens are differentially local-
ized in the basal laminas (BLs) associated with intramuscular 
nerve fascicles. Whereas nidogen-1 is present at similar lev-
els in both peri- and endoneurial BL, nidogen-2 is enriched in 
perineurial BL. Most endoneurial BL expressed little nidogen-
2, but a few structures within the nerve fascicle did contain 
nidogen-2 (arrowheads). Double staining with antibodies to 
CD31/PECAM indicate that most nidogen-2-positive struc-
tures within nerve fascicles are not associated with capillaries 
(data not shown). (C, D) Nidogens are differentially localized 
in BLs associated with sensory muscle spindles. Nidogen-1 is 
enriched in BLs surrounding individual intrafusal fibers within 
the muscle spindle, but nidogen-2 is enriched in the capsular 
BL surrounding the entire spindle. (E-H) Nidogen-1 and 2 are 
both present in BLs associated with vascular structures, 
including capillaries (E, F; arrowheads in E, G, H highlight cap-
illary BL) and arterioles (arrows in G, H). Scale bar in (B) is 
20 ?m for (A, B), in (D) is 10 ?m for (C, D), in (F) is 20 ?m 
for (E, F), and in (H) is 20 ?m for (G, H).
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Nidogen-2 is necessary for maturation and maintenance of 
the NMJ
Targeted nidogen-2 null mutant mice are viable and fer-
tile, and no structural or functional defects have been
detected in them to date [33,36]. To seek abnormalities in
NMJs of nidogen-2 mutants, we labelled whole mounts of
diaphragm muscles from young adults (P56) with mark-
ers of pre- and postsynaptic specializations, anti-synapto-
tagmin 2 (a synaptic vesicle protein) and ?-bungarotoxin,
respectively, then imaged NMJs by confocal microscopy.
Although nerve terminals and postsynaptic membranes
were closely apposed to each other, and obviously func-
tional, the topology of the synapse was abnormal in
mutants. In controls, NMJs appear 'pretzel-like', with con-
tinuous, branched AChR clusters (Figure 5A). In mutants,
many NMJs appeared fragmented, with AChRs clustered
into small, separate islands (Figure 5B, D, E). Others were
plaque-like (Figure 5C), a shape characteristic of neonatal
NMJs [45]. Thus, although nidogen-2-deficient NMJs are
functional, their structure is aberrant.
Neuromuscular abnormalities observed in nidogen-2
mutants could reflect a role of nidogen-2 in the forma-
tion, maturation or maintenance of the NMJ. To distin-
guish these possibilities, we examined mutant muscles at
P7, when NMJs are quite immature, and at P21, soon after
Developmental regulation of nidogens and laminin ? chains in synaptic basal lamina (BL)Figure 4
Developmental regulation of nidogens and laminin ? chains in synaptic basal lamina (BL). Cross-sections of mus-
cle from P0 (A, D, G, J), P14 (B, E, H, K) and P21 (C, F, I, L) mice, stained for ?-bungarotoxin (BTX) and nidogens or laminins. 
(A-F) While nidogen-1 expression changes little during development (A-C), nidogen-2 is present in both synaptic and extrasy-
naptic BLs at birth (D) and becomes restricted to synaptic BL postnatally (E, F). (G-L) Laminins ?4 (G-I) and ?5 (J-L) become 
restricted to synaptic BL in parallel with nidogen-2. Scale bar is 15 ?m for (A, D, G, J) and 10 ?m for all other panels.
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the early postnatal period of synapse elimination is com-
plete [39]. No obvious defects were observed in nidogen-
2 mutants at either age (Figure 6A, B). Thus, nidogen-2
appears to be dispensable for formation and remodelling
of the NMJ, but required for its full maturation or mainte-
nance. To ask whether the defects are progressive, we
examined diaphragms from 1-year-old nidogen-2
mutants. Defects were not appreciably more severe in 12-
month-old mutants than in 2-month-old mutants. Thus,
nidogen-2 is required for final stages in the maturation of
the NMJ.
To test whether defects in NMJ morphology were second-
ary to muscle damage, we searched for muscle fiber degen-
eration in nidogen-2-deficient muscle. In healthy muscle,
myonuclei are concentrated in the periphery of muscle
fibers. In fibers that have undergone degeneration and
regeneration, however, myonuclei are centrally located
[46]. Less than 4% of mutant muscle fibers contained cen-
tral nuclei (data not shown), whereas up to 80% of NMJs
were abnormal (see below). Thus, defects in synaptic
structure in nidogen-2-deficient mice were not the result
of degenerating muscle fibers.
How might nidogen-2 promote maturation or enhance
maintenance of the NMJ? Nidogens are capable of bind-
ing various cell surface receptors that are both present in
pre- or postsynaptic membranes and necessary for synap-
Aberrant neuromuscular junction (NMJ) morphology in the absence of nidogen-2Figu e 5
Aberrant neuromuscular junction (NMJ) morphology in the absence of nidogen-2. NMJs from diaphragms of P56 
nid2-/- mutants and aged-matched controls. Pre- and postsynaptic elements are labeled with anti-synaptotagmin 2 (syt 2) and ?-
bungarotoxin (BTX). (A) In controls, NMJs appeared pretzel-like. (B-E) In mutants, NMJs were frequently fragmented into 
small clusters (B, D, E) or appeared plaque-like (C). Despite topological abnormalities, mutant pre- and postsynaptic elements 
remain precisely aligned (B"). Scale bar in (A) is 10 ?m for all parts.
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Morphological defects in nid2-/- neuromuscular junctions (NMJs) are due to improper maturation and maintenanceFigure 6
Morphological defects in nid2-/- neuromuscular junctions (NMJs) are due to improper maturation and mainte-
nance. (A, B) NMJs from diaphragms of P7 (A) and P21 (B) nid2-/- mutants and aged-matched controls. Pre- and postsynaptic 
elements are labeled with anti-synaptotagmin 2 antibodies (syt 2) and ?-bungarotoxin (BTX), respectively. No obvious defects 
were present at either age. (C) NMJs from diaphragms of 1-year-old mutants and age-matched controls. Mutant NMJs were 
fragmented at 1 year of age but were not appreciably more severely affected than in 2-month-old mutants (Figure 5). Scale bars 
are 20 ?m.
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togenesis; these include integrins and leukocyte-common
antigen related (LAR) receptor tyrosine phosphatase
[3,37,39,47]. Therefore, one possible explanation for the
defects in nidogen-2-deficient NMJs is that nidogen-2
exerts direct effects by binding receptors on either the
motor nerve terminal or the postsynaptic apparatus. To
test this idea, we used assays previously applied to identify
and characterize other synaptic organizing molecules. For
presynaptic differentiation, we applied soluble recom-
binant nidogen-1 or -2 to cultured chick motor neurons,
and grew motoneurons on substrates coated with a mix-
ture of recombinant nidogen and laminin-111. In both
cases, we assayed the ability of nidogen to promote clus-
tering of synaptic vesicles into aggregates such as those
found in nerve terminals [48,49]. We also asked whether
nidogens affected the length or branching of motor neur-
ites. Neither nidogen-1 nor -2 detectably affected motor
neurons under these conditions. For postsynaptic differ-
entiation, we assayed the aggregation of AChRs in cul-
tured myotubes [14,20,42]. In these assays, nidogen
appeared to be detrimental to the health of the myotubes,
so it was not possible to gauge their synaptic effects. Thus,
these in vitro studies provide no evidence for a direct effect
of nidogen on nerve or muscle, although we cannot draw
definitive conclusions from them.
Another possible explanation for the defects in nidogen-
2-deficient NMJs is that nidogen-2 might be required to
recruit or retain other synaptic BL components that are, in
turn, required for synaptic integrity. To test this possibil-
ity, we immunostained nidogen-2 mutant muscle with a
panel of antibodies to synaptic BL components. As
expected, no nidogen-2 was present in mutants (Figure
7A). Although nidogen-2 is upregulated in some tissues of
nidogen-1 mutants [50], we failed to detect any changes
of nidogen-1 level at nidogen-2-deficient synapses (Figure
7B, compare with Figure 2A). The major synapse-specific
laminin subunits – laminin ?4, ?5, and ?2 – as well as
agrin and the synapse-specific collagens ?3–6(IV) were all
retained in synaptic BL in the absence of nidogen-2 (Fig-
ure 7C–J). Neither levels nor distribution of these proteins
were detectably affected by the absence of nidogen-2,
although we would not have detected small changes.
From these results, we conclude that neuromuscular
defects in nidogen-2 mutants are not indirect conse-
quences of loss of synaptic laminins, collagens IV or agrin.
A third possibility is that nidogen-2 selectively binds and
presents a matrix-associated synaptic organizing molecule
to nerve or muscle. Indeed, several bioactive matrix mole-
cules have been reported to bind with much higher affin-
ity to nidogen-2 than nidogen-1, including tropoelastin,
collagen XIII and collagen XVIII/endostatin [37,51-53].
Interestingly, we have found that mice with a targeted
mutation of the collagen XIII gene have neuromuscular
defects [54], and recent studies have shown that collagen
XVIII is critical for motor axon growth and NMJ formation
in C. elegans and zebrafish [26,55,56]. We therefore used
immunohistochemical methods to ask whether synaptic
localization of collagens XIII and XVIII are perturbed in
nid2-/- mice. Collagen XIII was concentrated at NMJs in
control muscle, as reported previously [54,57] and this
concentration persisted in the absence of nidogen-2,
although we cannot rule out the possibility that its level
may be modestly affected (data not shown). In both con-
trol and nid2-/- muscles, collagen XVIII was undetectable
in synaptic BL, although it was associated with the BL of
terminal Schwann cells (data not shown). Thus, the mech-
anisms by which nidogen-2 contributes to synaptic matu-
ration and maintenance remain to be determined.
Intermuscular differences in the role of nidogen-2
Recently, we and others have observed striking intermus-
cular differences in neuromuscular phenotypes in
mutants lacking agrin or collagen IV chains ?3–6
[12,58,59]. The explanation for these differences remains
unknown, but they are of interest because they may pro-
vide clues to mechanisms by which BL components act or
muscles diversify. We therefore extended our study from
diaphragm to three limb muscles – the extensor digitorum
longus, soleus and tibialis anterior (Figure 8A–D). The
soleus is a predominantly slow muscle; extensor digito-
rum longus and tibialis anterior are predominantly fast;
and diaphragm is mixed. Nidogen-2 was concentrated at
synaptic sites in limb muscles as well as in diaphragm (for
example, Figure 2 shows limb muscle and Figure 4 shows
diaphragm). Nonetheless, the percentage of abnormal
junctions varied among muscles from approximately 20%
in extensor digitorum longus to 75% in diaphragm (Fig-
ure 8E). Likewise, of those NMJs that were malformed, the
ratio of those that were fragmented to those that were
immature varied from 9:1 in extensor digitorum longus to
2:1 in diaphragm (Figure 8E). Intermuscular differences
were less striking in 1-year-old mice, owing to a progres-
sive accumulation of defects in mutant extensor digito-
rum longus and tibialis anterior muscles (data not
shown). Thus, mutant muscles may vary in the rate at
which defects accumulate rather than in their absolute
susceptibility.
Muscles, and the NMJs within them, differ from each
other in many respects [60] and it is not clear whether any
documented factors explain the intermuscular differences
we have observed. It is intriguing that NMJs more depend-
ent on the presence of nidogen-2 are found in constantly
active muscles (that is, diaphragm muscle controls respi-
ration and soleus muscle controls lower limb posture),
whereas fewer defects are observed in young, phasically
active muscles (tibialis anterior and extensor digitorum
longus). Another distinction is between two categories of
Neural Development 2008, 3:24 http://www.neuraldevelopment.com/content/3/1/24
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muscles described by Pun et al. [58]. Called 'fast synaps-
ing' or 'fasyn' and 'delayed synapsing' or 'desyn,' they were
initially distinguished by the tempo and pattern of NMJ
formation within them during embryogenesis. They were
subsequently shown to differ in their sensitivity to nerve
injury and neurological disease [58,61,62]. Interestingly,
the two muscles we examined that were most severely
affected, diaphragm and soleus, are both 'delayed synaps-
ing' muscles, whereas the two muscles less affected in
nid2-/- mice, tibialis anterior and extensor digitorum lon-
gus, are 'fast synapsing' muscles [58].
Independent localization of synaptic BL components
Biochemical studies have shown that interactions among
three main structural components, laminins, collagens IV,
and nidogens, are involved in BL assembly [63,64]. More-
over, all three of these components bind to HSPGs [4,63].
Our results have shown that specific isoforms of all four
Nidogen-2 is not required to restrict other basal lamina (BL) components to the synaptic BLFigur  7
Nidogen-2 is not required to restrict other basal lamina (BL) components to the synaptic BL. (A-J) Synaptic sites 
in P56 nid2-/- muscle cross sections were labeled with ?-bungarotoxin (BTX) and antibodies to BL components: nidogen-1 (B) 
and -2 (A), synaptic laminin chains (Lam?4 [C], Lam?5 [D], and Lam?2 [E] chains), agrin (F), and synaptic collagens IV (Col?3–
6 [IV]) (G-J). No other components of the synaptic BL appeared altered in the absence of nidogen-2. Scale bar is 10 ?m.
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components are colocalized in synaptic BL. One might
therefore presume that interactions among synaptic iso-
forms would mediate assembly of this specialized
domain. Yet, we found that nidogen-2 is dispensable for
the synaptic localization of synaptic laminins, collagens
IV and agrin (Figure 7). We therefore considered the alter-
native possibility, that other synaptic BL components
might be required for synaptic localization of nidogen-2.
To test this idea, we examined the distribution of nidogen-
2 in four mutants lacking synaptic laminin chains (?2, ?4,
?5, or both ?4 and ?5) and in collagen ?5(IV) mutants,
which lack all four synaptic collagen IV chains (?3–6)
[12]. It was not possible to assess nidogen-2 in agrin
mutants since these mice die at birth [21], prior to the syn-
aptic restriction of nidogen-2.
Fragmentation and immaturity similar to that observed in
nidogen-2 mutants has been reported in collagen ?5(IV)
and laminin ?4 mutants and in laminin ?4/?5 double
mutants, respectively [12,18,19]. However, nidogen-2
remained concentrated in the synaptic BL of NMJs in all of
these mutants (Figure 9). Thus, synaptic laminins and col-
lagens IV are dispensable for concentrating nidogen-2 in
the synaptic cleft. Moreover, the absence of nidogen-2 is
not responsible for fragmentation of synapses lacking syn-
aptic laminins or collagens IV.
Finally, we broadened our inquiry to ask whether any syn-
aptic BL components are necessary for the recruitment
and restriction of other BL components to the synaptic
cleft. As noted above, nidogen-2 is not required for synap-
tic localization of laminins, collagens IV or agrin, nor does
it require synaptic laminins or collagens IV to become syn-
aptically localized. On the other hand, previous results
show that loss of a single laminin subunit or collagen IV
chain can lead indirectly to absence of other components
of the trimer from the synaptic cleft [9,12,65]. Here, we
asked whether synaptic laminins are required for localiza-
tion of synaptic collagens IV or visa versa. We found that
synaptic collagens as well as agrin are normally localized
to the NMJ in mutants lacking laminins ?2, ?4, or ?5, and
that synaptic laminins as well as agrin are normally local-
ized to the NMJ in mutants lacking synaptic collagens ?3–
6(IV) (Figure 10 and data not shown). Together, these
results, summarized in Table 1, indicate that the localiza-
tion of each family of synaptic BL components occurs
independently of other BL components.
Conclusion
We report here that nidogen-2 is selectively associated
with synaptic BL at the NMJ and required for maturation
or maintenance of this synapse. Combined with previous
studies on laminins, collagens IV and HSPGs, these find-
ings establish that each of the four major families of BL
components has isoforms that are enriched in synaptic BL
Nidogen-2 phenotypes vary among musclesFigur  8
Nidogen-2 phenotypes vary among muscles. (A-C) 
Neuromuscular junction (NMJ) morphology was differentially 
affected in different muscles. Like diaphragm (Dia) (A), most 
NMJs in soleus (Sol) muscles were fragmented or immature 
(B), whereas NMJs in tibialis anterior (TA) and extensor digi-
torum longus (EDL) appeared less affected (C, D). NMJs 
were labeled with only ?-bungarotoxin. (E) Quantification of 
NMJ morphology in several different mutant and control 
muscles. Y-axis represents the percentage of NMJs appearing 
either pretzel-like (that is, normal), fragmented (blue, as in 
Figure 6B, D, E), or immature (red, as in Figure 6C). Control 
tibialis anterior, n = 92 NMJs from 3 animals. Control dia-
phragm, n = 100 NMJs from 3 animals. Nid2-/- EDL, n = 105, 
from 3 animals. Nid2-/- tibialis anterior, n = 91, from 3 ani-
mals. Nid2-/- soleus, n = 129, from 3 animals. Nid2-/- dia-
phragm; n = 384, from 3 animals. Scale bar in (D) is 25 ?m 
for (A-D).
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and required for synaptogenesis: laminins ?4, ?5, and ?2,
collagens ?3–6(IV), agrin [7-9,11,12,15] (reviewed in
[4,5,39], and nidogen-2. It remains unclear whether
nidogen-2 interacts directly with receptors embedded in
synaptic membranes or whether it acts by concentrating
and presenting other synaptogenic factors. In C. elegans it
has been proposed that nidogen exerts it synaptic organ-
izing activity through a receptor protein tyrosine phos-
Nidogen-2 localized to synaptic sites in the absence of other synaptic basal lamina componentsFigur  9
Nidogen-2 localized to synaptic sites in the absence of other synaptic basal lamina components. (A-E) Nidogen-2 
was properly localized at synaptic sites (labeled with ?-bungarotoxin (BTX)) in mutant mice lacking laminin ?4 (lama4-/-) (A), 
laminin ?5 (lama5M/M:HSA-Cre) (B), both laminin ?4 and ?5 (lama4-/-; lama5M/M:HSA-Cre) (C), laminin ?2 (lamb2-/-) (D) and all 
four synaptic collagen IV chains (col4a5-/Y) (E). Scale bar is 5 ?m.
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phatase present in presynaptic terminals [47]. We are
currently testing the possibility that one or more members
of this large family may be present at the NMJ. Impor-
tantly, synaptic functions of nidogen-2 cannot be fully
compensated for by nidogen-1, so receptors or ligands
mediating this effect are likely to selectively bind nidogen-
2.
Table 1: Enrichment of laminins, collagens IV, nidogen 2 and agrin in synaptic basal lamina of mutant mice
Enrichment in synaptic basal lamina
Laminin Collagen IV
Mouse mutants ?4 ?5 ?2 ?3 ?4 ?5 ?6 Nidogen 2 Agrin
lama4-/- - + + + + + + + +
lama5M/M; HSA-Cre + - + + + + + + +
lama4-/-; lama5M/M; HSA-Cre - - + + + + + + +
lamb2-/- + - - + + + + + +
col4a5-/Y + + + - - - - + +
nid2-/- + + + + + + + - +
Includes data from this and previously published studies [9,12,16,18].
Synaptic localization of laminins, collagens IV and agrin occurs independently of other major basal lamina (BL) componentsFigure 10
Synaptic localization of laminins, collagens IV and agrin occurs independently of other major basal lamina (BL) 
components. (A-G) In addition to nidogen-2 (Figure 9) other components of synaptic BL were examined in mutant mice lack-
ing all four synaptic collagen IV chains (col4a5-/Y) (A-D) and collagen ?3(IV) in laminin ?2 (lamb2-/-) (E), laminin ?4 (lama4-/-) (F) 
and laminin ?5 (lama5M/M:HAS-Cre) (G) mutants. In the absence of any synaptic BL component, other families of BL molecules 
remained properly enriched at synaptic sites. Scale bar is 5 ?m.
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Our studies also provide the foundation for analyzing
assembly of the synaptic cleft. Biochemical evidence has
suggested that laminins, collagens IV, and nidogens are all
necessary for BL assembly: laminins for initial BL forma-
tion; collagens IV for BL stabilization and maintenance;
and nidogens for cross-linking laminin and collagen IV
networks [36,66-68]. At the NMJ, however, the synaptic
localization of each class of BL component appears to be
independent of the others. Although it is possible that
multiple, redundant interactions stabilize the synaptic
cleft when a single component is removed, a more attrac-
tive idea is that synaptic laminins, collagens IV, HSPGs
and nidogen are all localized by interactions with compo-
nents of pre- or postsynaptic membranes. Previous studies
have defined sites important for synaptic localization of
laminin ?2 and suggested that the receptor tyrosine kinase
MuSK may be a localizing receptor for laminins or acetyl-
cholinesterase [69-71]. Further analysis of how synaptic
BL components are localized may provide a good model
for understanding how the much less accessible synaptic
cleft of central synapses is organized.
Materials and methods
Animals
Targeted mutant and transgenic mice used in this study
have been described previously. They are: nidogen-2
mutants (nid2-/-) [31], laminin ?2 mutants (lamb2-/-) [16],
laminin ?4 mutants (lama4-/-) [18], collagen ?5(IV)
mutants (col4a5-/Y) [72], obtained from Jackson Laborato-
ries, Bar Harbor, ME, USA), conditional laminin ?5
mutants (lama5flox/flox) [73], and mice that express Cre
selectively in skeletal muscle (HSA-Cre) [74]. Mutants
lacking laminin ?5 selectively in skeletal muscle were gen-
erated by crossing lama5flox/flox and HAS-Cre mice; we refer
to the lama5flox/flox;HSA-Cre mice as lama5M/M. Mice lack-
ing both laminin ?4 and ?5 (lama4-/-; lama5M/M) were
generated by crossing lama4-/-;lama5flox/+; HSA-Cre males
and females. All mutants and transgenics were main-
tained on a C57/B6 background. In most cases, littermates
of mutants were used as controls. CD1 mice were
obtained from Charles River Laboratories, Inc. (Wilming-
ton, MA, USA). All analyses conformed to NIH guidelines
and were carried out under an animal protocol approved
by the Harvard University Standing Committee on the
Use of Animals in Research and Teaching.
Antibodies
Primary antibodies used in this study are listed in Table 2.
All fluorescently labeled secondary antibodies were
obtained from Invitrogen/Molecular Probes and were
used at a 1:1000 dilution. HRP-conjugated secondary
antibodies from Vector Laboratories (Burlingame, CA,
USA) were used at a dilution of 1:5000.
Western blotting
Full-length human nidogen-1 and -2 fusion proteins were
purchased from R&D Systems (Minneapolis, MN, USA).
Recombinant proteins (250 ng) were denatured by boil-
ing in Laemmli buffer and separated by SDS-PAGE. Elec-
trophoretically separated proteins were transferred to
Immuno-Blot PVDF membrane (Bio-Rad, Hercules, CA,
USA) in Tris-Glycine buffer (25 mM Tris, 190 mM glycine,
pH 8.4)/20% methanol at 300 mA for 2 hours. Immuno-
blotted proteins were detected as previously described
[75].
Immunostaining
Mice were perfused with phosphate-buffered saline (PBS)
and tibialis muscles were dissected. Tissue was immedi-
ately frozen in OCT on dry ice and 4 ?m sections were cut
on a cryostat. Sections were collected on gelatin-coated
slides and allowed to air-dry for 15 minutes before tissue
was fixed by incubating in ice-cold acetone for 10 min-
utes. For collagen IV antibodies, tissue was treated for 10
minutes in a 1:1 mix of 1 M KCl and 1 M HCl following
fixation [12]. Sections were washed several times in PBS to
remove any residual acid. After fixation, tissue was incu-
bated with blocking buffer (5% non-fat milk in PBS with
0.2% Triton-X100 in PBS) for 30 minutes. Primary anti-
bodies, diluted in blocking buffer, were incubated on the
Table 2: Antibodies used in this study
Antigen Isotype Source Dilution Reference
Nidogen-1 Rabbit IgG Abcam, Inc. 1:2000 Figure 1
Nidogen-2 Rabbit IgG Abcam, Inc. 1:2000 Figure 1
znp-1 (Synaptotagmin 2) Mouse IgG2a Zebrafish International Resource Center 1:200 [76,77]
Collagen ?3(IV) Rat IgG Gift of Y Sado (Shigei Medical Research Institute, Okayuma) 1:100 [78]
Collagen ?4(IV) Rat IgG Gift of Y Sado 1:100 [78]
Collagen ?5(IV) Rabbit IgG Generated in our lab 1: 2000 [11]
Collagen ?6(IV) Rat IgG Gift of Y Sado 1:25 [78]
Laminin ?2 Rabbit IgG Gift of T Sasaki and R Timpl (Max Plank Institute, Munich) 1:1000 [79]
Laminin ?4 Rabbit IgG Kind gift of T Sasaki and R Timpl 1:1000 [80]
Laminin ?5 Rabbit IgG Generated in our lab 1:2000 [81]
Agrin Rabbit IgG Gift of Z Hall (UCSF) 1:300 [82]
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sections for 12 hours at 4°C, then sections were washed
several times with PBS. Secondary antibodies, diluted in
blocking buffer, were then incubated on the slides for 1
hour at room temperature. For controls, primary antibody
incubation was omitted from the immunostaining proto-
col described above. Sections were washed thoroughly
with PBS, cover-slipped with VectaShield, and visualized
on an Olympus FV1000 scanning confocal microscope
(Olympus America Inc., Melville, NY, USA).
Cell culture
C2C12 cells (ATCC, Manassas, VA, USA) were cultured as
previously described by Kummer et al. [42]. Myotubes
were fixed with ice-cold acetone and stained as described
above.
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